AARNet
AARNet is Australia’s national research and education network, a not-for-profit organisation equally owned by 38 Australian universities and CSIRO. AARNet provides essential high-speed internet and advanced network services tailored to meet the specialised needs of researchers in Australia.
Unlocking the power of Australia’s Tier 1 supercomputer
Through a national framework for trusted identity, accessing one of Australia’s Tier 1 supercomputers will become easier. The Pawsey Supercomputing Research Centre (Pawsey) is one of two Tier-1 high-performance computing facilities in Australia. Its primary function is to accelerate scientific research for the benefit of the nation. Pawsey’s service and expertise in supercomputing, data, cloud […]
State support injects big cash for upgrades and new national research infrastructure
National Collaborative Research Infrastructure Strategy (NCRIS)-supported programs have received nearly $30 million in co-investment from the New South Wales and Queensland Governments through the NCRIS Support Program and Research Infrastructure Co-Investment Fund (RICF), respectively. Co-funding arrangements such as the NCRIS Support Program and RICF are another way that NCRIS ensures that spending on research infrastructure […]
Future-proofing computational proteomics
EMBL Australia and Bioplatforms Australia joined forces to host a pivotal proteomics workshop titled ‘Future-proofing Computational Proteomics’ on 24 April, featuring leading guest speakers, Dr Rolf Apweiler, Prof Marc Wilkins and Dr Richard Lipscombe. The Australian proteomics community discussed advancements in proteomics research and the pivotal role of computational approaches in shaping the future of […]
Protein discovery for better bowel cancer treatments
Bowel cancer claims more than 100 lives in Australia every week. Thankfully, researchers at the Australian National University (ANU) have discovered that an immune protein can slow the division of bowel cancer cells. This is a promising target for both early detection tests and bowel cancer treatments. DR ABHIMANU PANDEY SAYS AN IMMUNE SYSTEM PROTEIN […]
Pawsey Supercomputing Research Centre (Pawsey)
Pawsey Supercomputing Research Centre, Australia’s leading Tier-1 high-performance computing facility, is advancing research and innovation by providing cutting-edge supercomputing, data and visualisation infrastructure and expertise. From accelerating breakthroughs in medicine and climate science to unlocking the mysteries of the universe, Pawsey is at the forefront of driving discovery and advancing knowledge.
Phenomics Australia (PA)
Phenomics Australia provides a national capability to explore the human genome and the genetic basis of health and disease. Our openly accessible service delivery centres span twenty locations across Australia. Through these, we offer specialised infrastructure, research services and technical expertise dedicated to advancing our fundamental understanding of health and disease and enabling next-generation innovations in healthcare and therapeutic development to benefit all Australians.
Australian National Fabrication Facility (ANFF)
ANFF owns and provides access to micro and nanofabrication capabilities for Australia’s researchers and industry. We can assist in both the development of new products and improvements to current production methods. Each Node provides expertise in a specific area, including advanced materials, nanoelectronics & photonics and nano-bio applications. The ANFF commitment to providing a world-class, open-access user facility is underpinned by the sharing of best practice in service provision across the network.
Strengthening our European connections to EMBL and beyond
On a recent visit to EMBL Heidelberg, Ian Smith, Chair of the EMBL Australia Council, spoke about the synergies between EMBL and EMBL Australia, opportunities for collaboration and ideas for exciting future programs. Ian Smith, Chair of the EMBL Australia Council, chatted to EMBL about the synergies between the organisations, opportunities for collaboration, and ideas […]
Vaccine patch delivers protection from dengue in mice
Dengue is the most significant mosquito-borne viral disease in the world. With an estimated 390 million cases annually, it results in approximately US$6.9 billion in economic losses. Now Dr David Muller and the vaccine team at the University of Queensland (UQ) have developed a promising dengue vaccine candidate that provides strong immunity in mice when […]
